Covered recipient · General Payments record
JAY S EDMONDS
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2023
$4,071.22
- Reported across 250 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $347.35 | 15 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $49.91 | 2 |
| Abbott Laboratories | $40.69 | 2 |
| Mylan Specialty L.P. | $38.00 | 1 |
| Novo Nordisk AS | $36.86 | 2 |
| GlaxoSmithKline, LLC. | $35.59 | 2 |
| Amgen Inc. | $32.77 | 1 |
| DEXCOM, INC. | $28.02 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $26.29 | 1 |
| PFIZER INC. | $22.22 | 1 |
| Exact Sciences Corporation | $20.99 | 1 |
| ABBVIE INC. | $16.01 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $23.69 | 05/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1018700341 | CMS |
| Abbott Laboratories | $17.00 | 07/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1018701323 | CMS |
| AbbVie Inc. | $16.01 | 06/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996791469 | CMS |
| Amgen Inc. | $32.77 | 03/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1019956495 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $26.29 | 02/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996567463 | CMS |
| Dexcom, Inc. | $28.02 | 06/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1054594805 | CMS |
| Exact Sciences Corporation | $20.99 | 02/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1026741175 | CMS |
| GlaxoSmithKline, LLC. | $17.28 | 07/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002821221 | CMS |
| GlaxoSmithKline, LLC. | $18.31 | 10/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002821211 | CMS |
| Lilly USA, LLC | $27.24 | 06/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031704263 | CMS |
| Lilly USA, LLC | $22.67 | 08/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031559397 | CMS |
| Mylan Specialty L.P. | $38.00 | 03/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1039125631 | CMS |
| Novo Nordisk Inc | $12.70 | 03/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000961717 | CMS |
| Novo Nordisk Inc | $24.16 | 07/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000961731 | CMS |
| PFIZER INC. | $22.22 | 11/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049420889 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.